A study of AZD0486 plus Rituximab in previously untreated Follicular Lymphoma patients

Trial Identifier:	D7401C00001
Sponsor:	AstraZeneca
Start Date:	August 2024
Primary Completion Date:	April 2031
Study Completion Date:	February 2035

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
AU	Macquarie University, AU, 2109
AU	Nedlands, AU, 6009
BE	Brussels, BE, 1070
BE	Brussels, BE, 1090
BE	Gent, BE, 9000
BE	Mechelen, BE, 2800
CA, ON	Hamilton, ON, CA, L8V 5C2
CA, ON	Oshawa, ON, CA, L1G 2B9
CA, QC	Chicoutimi, QC, CA, G7H 5H6
CA, QC	Montreal, QC, CA, H4J 1C5
CN	Beijing, CN, 100142
CN	Tianjin, CN, 300020
ES	Barcelona, ES, 8036
ES	Barcelona, ES, 08035
ES	El Palmar, ES, 30120
ES	Girona, ES, 17007
ES	Las Palmas de Gran Canaria, ES, 35020
ES	Madrid, ES, 28040
ES	Madrid, ES, 28041
ES	Oviedo, ES, 33011
ES	Pamplona, ES, 31008
ES	Santander, ES, 39008
FI	Helsinki, FI, 00029
FI	Kuopio, FI, 70029
FI	Tampere, FI, 33520
GB	London, GB, EC1M6BQ
HK	Hong Kong, HK, 999077
HK	Shatin, HK, 00000
HU	Budapest, HU, 1122
JP	Koto-ku, JP, 135-8550
JP	Okayama-shi, JP, 700-8558
KR	Seoul, KR, 06351
KR	Seoul, KR, 05505
KR	Seoul, KR, 13620
PL	Gliwice, PL, 44-102
SE	Falun, SE, 79182
TW	Changhua, TW, 50006
TW	Kaohsiung city, TW, 833
TW	Kaohsiung City, TW, 80756
TW	Lukang Township, TW, 505029
TW	Tainan City, TW, 704
TW	Taipei City, TW, 106

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company